Literature DB >> 17452182

Severe retinal thermal injury after indocyanine green-mediated photothrombosis for central serous chorioretinopathy.

Fernando M Penha1, Fabio B Aggio, Pedro P Bonomo.   

Abstract

PURPOSE: To report severe retinal thermal damage after indocyanine green-mediated photothrombosis (IMP) for chronic central serous chorioretinopathy (CSC).
DESIGN: Interventional case report.
METHODS: A 31-year-old white male underwent IMP for chronic CSC.
RESULTS: During the procedure, retinal whitening was observed in the area of the treatment spot. Fluorescein angiography revealed staining of the retinal arteries in the treated area. One year later, macular retinal pigment epithelial (RPE) changes were seen, accompanied by severe loss of vision.
CONCLUSIONS: IMP has been described as a relatively safe treatment option for persistent CSC. However, we herein report a case in which severe retinal damage occurred as a consequence of the treatment. We thus alert clinicians of this potential adverse event.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17452182     DOI: 10.1016/j.ajo.2006.12.008

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN: 0002-9394            Impact factor:   5.258


  4 in total

1.  Indocyanine green enhanced subthreshold diode-laser micropulse photocoagulation treatment of chronic central serous chorioretinopathy.

Authors:  F Ricci; F Missiroli; F Regine; M Grossi; G Dorin
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2008-12-17       Impact factor: 3.117

2.  Role of Avastin in management of central serous chorioretinopathy.

Authors:  Shaaban A Mehany; Ahmad M Shawkat; Mohamed F Sayed; Khaled M Mourad
Journal:  Saudi J Ophthalmol       Date:  2010-10-04

3.  Intravitreal Bevacizumab for Treatment of Central Serous Chorioretinopathy.

Authors:  Cihan Ünlü; Gurkan Erdogan; Tugba Aydogan; Betul Ilkay Sezgin Akcay; Esra Kardes; Gulunay Akcali Kiray; Tahir Kansu Bozkurt
Journal:  J Ophthalmic Vis Res       Date:  2016 Jan-Mar

4.  Intravitreal Ziv-Aflibercept in Treatment of Naïve Chronic Central Serous Chorioretinopathy Related Choroidal Neovascular Membrane.

Authors:  Nishant Radke; Charudutt Kalamkar; Amrita Mukherjee; Snehal Radke
Journal:  Case Rep Ophthalmol Med       Date:  2017-11-23
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.